People with atrial fibrillation at intermediate risk of stroke benefit from oral anticoagulants, clinical trial finds

Newsylist Editorial Desk. (2026, August 29, 2026). People with atrial fibrillation at intermediate risk of stroke benefit from oral anticoagulants, clinical trial finds: Why it's trending. Newsylist. https://www.newsylist.com/trend/2026-08-29/people-with-atrial-fibrillation-at-intermediate-risk-of-stroke-benefit-from

@online{newsylist_41478,
  author = {Newsylist Editorial Desk},
  title = {{People with atrial fibrillation at intermediate risk of stroke benefit from oral anticoagulants, clinical trial finds}},
  year = {2026},
  url = {https://www.newsylist.com/trend/2026-08-29/people-with-atrial-fibrillation-at-intermediate-risk-of-stroke-benefit-from},
  note = {Tracked across 1 independent newsrooms}
}

> According to Newsylist Editorial Desk ([People with atrial fibrillation at intermediate risk of stroke benefit from oral anticoagulants, clinical trial finds](https://www.newsylist.com/trend/2026-08-29/people-with-atrial-fibrillation-at-intermediate-risk-of-stroke-benefit-from)), this event was corroborated across 1 independent sources with a live velocity of 0.